tradingkey.logo

tradingkey.logo
怜玢


Icecure Medical Ltd

ICCM
りォッチリストに远加
0.681USD
-0.009-1.30%
終倀 11-05 16:00ET
2.34M時䟡総額
損倱額盎近12ヶ月PER

Icecure Medical Ltdに぀いお 䌁業名

Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.

Icecure Medical Ltd プロフィヌル


䌁業コヌドICCM
䌚瀟名Icecure Medical Ltd
䞊堎日Feb 02, 2011
最高経営責任者「CEO」Shamir (Eyal)
埓業員数64
蚌刞皮類Ordinary Share
決算期末Feb 02
本瀟所圚地7 Ha'eshel St.
郜垂CAESAREA
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Israel
郵䟿番号3079504
電話番号97246230333
りェブサむトhttps://icecure-medical.com/
䌁業コヌドICCM
䞊堎日Feb 02, 2011
最高経営責任者「CEO」Shamir (Eyal)

Icecure Medical Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Meir Peleg
Mr. Meir Peleg
Chief Financial Officer
Chief Financial Officer
194.82K
+93.16%
Mr. Eyal Shamir
Mr. Eyal Shamir
Chief Executive Officer, Director
Chief Executive Officer, Director
28.72K
+31.49%
Mr. Oded Tamir
Mr. Oded Tamir
External Director
External Director
20.00K
+50.00%
Mr. Ronen Tsimerman
Mr. Ronen Tsimerman
Vice President - Finance, Vice President - Operations
Vice President - Finance, Vice President - Operations
14.80K
+20.02%
Mr. Naum Muchnik
Mr. Naum Muchnik
Vice President - Research & Development
Vice President - Research & Development
6.80K
+31.16%
Ms. Elisabeth Sadka
Ms. Elisabeth Sadka
Vice President-Clinics, Regulations and Quality Assurance
Vice President-Clinics, Regulations and Quality Assurance
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
External Director
External Director
--
--
Mr. Doron Birger
Mr. Doron Birger
Independent Director
Independent Director
--
--
Mr. Ron Abraham Mayron
Mr. Ron Abraham Mayron
Chairman of the Board
Chairman of the Board
--
--
Ms. Tlalit Bussi Tel-Tzure
Ms. Tlalit Bussi Tel-Tzure
Vice President - Business Development & Marketing
Vice President - Business Development & Marketing
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Meir Peleg
Mr. Meir Peleg
Chief Financial Officer
Chief Financial Officer
194.82K
+93.16%
Mr. Eyal Shamir
Mr. Eyal Shamir
Chief Executive Officer, Director
Chief Executive Officer, Director
28.72K
+31.49%
Mr. Oded Tamir
Mr. Oded Tamir
External Director
External Director
20.00K
+50.00%
Mr. Ronen Tsimerman
Mr. Ronen Tsimerman
Vice President - Finance, Vice President - Operations
Vice President - Finance, Vice President - Operations
14.80K
+20.02%
Mr. Naum Muchnik
Mr. Naum Muchnik
Vice President - Research & Development
Vice President - Research & Development
6.80K
+31.16%
Ms. Elisabeth Sadka
Ms. Elisabeth Sadka
Vice President-Clinics, Regulations and Quality Assurance
Vice President-Clinics, Regulations and Quality Assurance
--
--

よくある質問

Icecure Medical Ltdの䞊䜍5名の株䞻は誰ですか


Icecure Medical Ltdの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Meir Peleg

Icecure Medical LtdICCMの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Icecure Medical Ltdの株匏を保有しおいる機関は32瀟あり、保有株匏の総垂堎䟡倀は玄628.53Kで、党䜓の0.77%を占めおいたす。2025Q4ず比范しお、機関の持ち株は106962.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。